Explore
Validate
LearnMN1010B
antibody from Invitrogen Antibodies
Targeting: MAPT
DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MN1010B - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Tau Monoclonal Antibody (BT2), Biotin
- Antibody type
- Monoclonal
- Antigen
- Purifed from natural sources
- Description
- MN1010B targets Tau in ELISA and WB applications and shows reactivity with Bovine, Human, Non-human primate, and Rat samples. The MN1010B immunogen is purified bovine Tau. MN1010B detects Tau which has a predicted molecular weight of approximately 79 kDa.
- Reactivity
- Human, Rat, Bovine
- Host
- Mouse
- Conjugate
- Biotin
- Isotype
- IgG
- Antibody clone number
- BT2
- Vial size
- 50 µg
- Concentration
- 0.1 mg/mL
- Storage
- 4° C
Submitted references Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
The use of mouse models to study cell-to-cell transmission of pathological tau.
Insulin therapy modulates mitochondrial dynamics and biogenesis, autophagy and tau protein phosphorylation in the brain of type 1 diabetic rats.
Early postnatal lead exposure induces tau phosphorylation in the brain of young rats.
In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice.
Wang X, Smith K, Pearson M, Hughes A, Cosden ML, Marcus J, Hess JF, Savage MJ, Rosahl T, Smith SM, Schachter JB, Uslaner JM
PloS one 2018;13(4):e0195486
PloS one 2018;13(4):e0195486
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
Gibbons GS, Banks RA, Kim B, Changolkar L, Riddle DM, Leight SN, Irwin DJ, Trojanowski JQ, Lee VMY
Journal of neuropathology and experimental neurology 2018 Mar 1;77(3):216-228
Journal of neuropathology and experimental neurology 2018 Mar 1;77(3):216-228
The use of mouse models to study cell-to-cell transmission of pathological tau.
Narasimhan S, Lee VMY
Methods in cell biology 2017;141:287-305
Methods in cell biology 2017;141:287-305
Insulin therapy modulates mitochondrial dynamics and biogenesis, autophagy and tau protein phosphorylation in the brain of type 1 diabetic rats.
Santos RX, Correia SC, Alves MG, Oliveira PF, Cardoso S, Carvalho C, Duarte AI, Santos MS, Moreira PI
Biochimica et biophysica acta 2014 Jul;1842(7):1154-66
Biochimica et biophysica acta 2014 Jul;1842(7):1154-66
Early postnatal lead exposure induces tau phosphorylation in the brain of young rats.
Rahman A, Khan KM, Al-Khaledi G, Khan I, Attur S
Acta biologica Hungarica 2012 Dec;63(4):411-25
Acta biologica Hungarica 2012 Dec;63(4):411-25
In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice.
Yamada K, Cirrito JR, Stewart FR, Jiang H, Finn MB, Holmes BB, Binder LI, Mandelkow EM, Diamond MI, Lee VM, Holtzman DM
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011 Sep 14;31(37):13110-7
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011 Sep 14;31(37):13110-7
No comments: Submit comment
No validations: Submit validation data